Acute myeloid leukaemia
RecruitingStudy on Early Treatment Intensification for Acute Myeloid Leukemia with FLT3 Mutation Using Cytarabine, Midostaurin, and Daunorubicin Hydrochloride for Patients with Low Chemosensitivity
Study on Early Treatment Intensification for Acute Myeloid Leukemia with FLT3 Mutation Using Cytarabine, Midostaurin, and Daunorubicin Hydrochloride for Patients with Low Chemosensitivity
- Disease:Acute myeloid leukaemia
- Substances:CytarabineMidostaurin+1
Italy- Participants:18–64 years · 65+ years
- Substances:Cytarabine
- Sponsor:Fondazione Gimema Franco Mandelli Onlus








